Luke S. Gill

Articles

Maximizing Immuno-Oncology Clinical Trial Success

April 05, 2018

Cancer immunotherapies require different standards for evaluating their safety and effectiveness. Understanding these standards-and the other major challenges of immuno-oncology studies-is critical to drug development success.